CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
6.90
+0.50 (7.81%)
At close: Dec 5, 2025, 4:00 PM EST
6.97
+0.07 (1.01%)
After-hours: Dec 5, 2025, 5:01 PM EST
CapsoVision Employees
CapsoVision had 90 employees as of December 31, 2024.
Employees
90
Change
n/a
Growth
n/a
Revenue / Employee
$145,422
Profits / Employee
-$250,667
Market Cap
323.22M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
CV News
- 16 days ago - CapsoVision to Participate in the Benchmark 14th Annual Discovery Investor Conference - GlobeNewsWire
- 5 weeks ago - CapsoVision to Release Third Quarter 2025 Financial Results on Thursday, November 13, 2025 - GlobeNewsWire
- 4 months ago - CapsoVision to Release Second Quarter 2025 Financial Results on Thursday, August 14, 2025 - GlobeNewsWire
- 5 months ago - CapsoVision Announces Closing of Initial Public Offering - GlobeNewsWire
- 5 months ago - CapsoVision Announces Pricing of Initial Public Offering - GlobeNewsWire
- 5 months ago - U.S. IPO Weekly Recap: Consumer Collections Firm Leads 4 IPO Week, As Two Billion Dollar Listings Join The Pipeline - Seeking Alpha
- 6 months ago - CapsoVision Proposes IPO Terms For GI Tract Imaging Capsule Technology - Seeking Alpha
- 7 months ago - Medical device maker CapsoVision files for a $30 million IPO - Renaissance Capital